Company: GMRE
Filing Date: 2025-11-13
Form Type: 424B5
Source: 0001104659-25-110926
Chunk: 61

Company: Global Medical REIT Inc.
Filing Date: 2025-11-13
Form: 424B5
Chunk 61
---
 Our Option,”
or (ii) they are converted by the holder of such Series A Preferred Stock in the event of a Change of Control as described below in “—
Conversion Right upon a Change of Control.”

Ranking. Our Series A Preferred Stock ranks,
with respect to dividend rights and rights upon our voluntary or involuntary liquidation, dissolution or winding up:

| 1) | senior to our common stock and to any other class or series of our equity shares, currently issued or issued in the future, expressly 
 designated as ranking junior to the Series A Preferred Stock;                                                                         |

| 2) | on parity with any preferred or convertible preferred stock ranking on parity with the Series A Preferred Stock, currently issued 
 or issued in the future; and                                                                                                      |

| 3) | junior to all equity shares issued by us with terms specifically providing that those equity shares rank senior to the Series A Preferred   
 Stock with respect to rights of dividend payments and the distribution of assets upon any voluntary or involuntary liquidation, dissolution 
 or winding up of the Company, which issuance is subject to the approval of the holders of two-thirds of the outstanding shares of Series    
 A Preferred Stock and any parity preference shares.                                                                                         |

The term “equity shares” does not
include convertible or exchangeable debt securities, which debt securities would rank senior to the Series A Preferred Stock.

Dividends. Holders of Series A Preferred
Stock are entitled to receive, when, as and if declared by our board of directors or a duly authorized committee of the board of directors,
out of funds legally available for the payment of dividends under Maryland law, cumulative cash dividends from the original issue date
or the immediately preceding dividend payment date, as applicable, quarterly in arrears on January 31, April 30, July 31 and October 31
of each year (each, a “dividend payment date”). These cumulative cash dividends will accrue on the liquidation preference
amount of $25.00 per share at a rate per annum equal to 7.50% of the liquidation preference of $25.00 per share (equivalent to $1.875
per annum per share) with respect to each dividend period from and including the original issue date. If we issue additional shares of
Series A Preferred Stock after the original issue date, dividends on such shares will accrue from the original issue date or the most
recent dividend payment date at which dividends were paid in full.

Dividends will be payable to holders of